Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
4.110
0.00 (0.00%)
May 13, 2025, 4:00 PM - Market closed
Lantern Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 7.51 | 21.94 | 37.2 | 51.52 | 19.23 | Upgrade
|
| Short-Term Investments | 16.5 | 19.36 | 17.99 | 19.2 | - | Upgrade
|
| Cash & Short-Term Investments | 24.01 | 41.3 | 55.2 | 70.73 | 19.23 | Upgrade
|
| Cash Growth | -41.86% | -25.17% | -21.96% | 267.80% | 1460.78% | Upgrade
|
| Other Receivables | 0.1 | 0.86 | 0.59 | 0.18 | - | Upgrade
|
| Receivables | 0.1 | 0.86 | 0.59 | 0.18 | - | Upgrade
|
| Prepaid Expenses | 1.14 | 1.18 | 0.76 | 1.03 | 0.82 | Upgrade
|
| Restricted Cash | - | - | 0.54 | - | - | Upgrade
|
| Other Current Assets | - | - | 1.63 | 0.78 | 0.19 | Upgrade
|
| Total Current Assets | 25.25 | 43.34 | 58.72 | 72.72 | 20.24 | Upgrade
|
| Property, Plant & Equipment | 0.29 | 0.28 | 0.1 | 0.22 | 0.02 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 0.1 | Upgrade
|
| Other Long-Term Assets | 0.04 | 0.03 | 0.02 | 1.02 | - | Upgrade
|
| Total Assets | 25.57 | 43.65 | 58.84 | 73.95 | 20.36 | Upgrade
|
| Accounts Payable | 2.42 | 0.94 | 0.93 | 0.68 | 0.43 | Upgrade
|
| Current Portion of Leases | 0.19 | 0.17 | 0.05 | 0.15 | - | Upgrade
|
| Other Current Liabilities | 1.73 | 1.56 | 1.81 | 1.49 | 0.12 | Upgrade
|
| Total Current Liabilities | 4.33 | 2.68 | 2.8 | 2.33 | 0.55 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.11 | Upgrade
|
| Long-Term Leases | 0.05 | 0.06 | - | 0.05 | - | Upgrade
|
| Total Liabilities | 4.38 | 2.74 | 2.8 | 2.38 | 0.66 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 97.06 | 96.26 | 95.69 | 96.69 | 32.36 | Upgrade
|
| Retained Earnings | -76.03 | -55.24 | -39.28 | -25.02 | -12.66 | Upgrade
|
| Comprehensive Income & Other | 0.15 | -0.11 | -0.37 | -0.09 | - | Upgrade
|
| Total Common Equity | 21.19 | 40.91 | 56.04 | 71.57 | 19.7 | Upgrade
|
| Shareholders' Equity | 21.19 | 40.91 | 56.04 | 71.57 | 19.7 | Upgrade
|
| Total Liabilities & Equity | 25.57 | 43.65 | 58.84 | 73.95 | 20.36 | Upgrade
|
| Total Debt | 0.24 | 0.23 | 0.05 | 0.2 | 0.11 | Upgrade
|
| Net Cash (Debt) | 23.77 | 41.07 | 55.14 | 70.52 | 19.12 | Upgrade
|
| Net Cash Growth | -42.12% | -25.52% | -21.80% | 268.82% | 1451.97% | Upgrade
|
| Net Cash Per Share | 2.21 | 3.79 | 5.08 | 6.47 | 4.44 | Upgrade
|
| Filing Date Shares Outstanding | 10.78 | 10.74 | 10.86 | 10.78 | 11.17 | Upgrade
|
| Total Common Shares Outstanding | 10.78 | 10.72 | 10.86 | 11.09 | 6.22 | Upgrade
|
| Working Capital | 20.92 | 40.66 | 55.92 | 70.39 | 19.68 | Upgrade
|
| Book Value Per Share | 1.96 | 3.82 | 5.16 | 6.45 | 3.17 | Upgrade
|
| Tangible Book Value | 21.19 | 40.91 | 56.04 | 71.57 | 19.7 | Upgrade
|
| Tangible Book Value Per Share | 1.96 | 3.82 | 5.16 | 6.45 | 3.17 | Upgrade
|
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.